You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering treatment, 2010 or most recent year available
Part (ii) Inpatient units
| Country | Males | Females | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | ||
| Opiods | 23 | 30 | 8 | 22 | 30 | 8 | 22 | 30 | 8 | |
| Cocaine | 21 | 31 | 11 | 21 | 30 | 9 | 21 | 31 | 10 | |
| Stimulants | 19 | 28 | 9 | 18 | 25 | 6 | 19 | 27 | 8 | |
| Cannabis | 17 | 25 | 8 | 17 | 25 | 7 | 17 | 26 | 9 | |
Notes:
Countries included are: BE, BG, CZ, DK, DE, IE, GR, FR, CY, LV, HU, AT, RO, SK, FI, SE, HR, TR,
See also ‘General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — inpatient treatment centres.